*Cancer Flashcards
Colon cancer series of mutations
- APC tumor supressor gene lost
- KRAS oncogene activated
- DCC tumor supressor gene lost
- P53 tumor supressor gene lost
Cooperativity
The overexpression of multiple oncogenes results in increased tumor formation (myc, rasD)
Tumor Suppressor Gene
The brakes. Encode proteins that restrain cell growth. A mutation in BOTH alleles would cause cancer.
The proteins produced by tumor suppressor genes stop cell proliferation.
Oncogenes
Encode proteins that promote out-of-control growth and conversion of cell to a malignant state. Dominant: a mutation in one allele is enough to cause out of control growth.
Proto-oncogenes
genes that encode proteins for normal cell functioning, but can be converted to oncogenes
Proto-oncogenes activated in 3 ways:
- Gene with proto-oncogene is mutated, making a protein with altered structure or function
- The gene is duplicated, leading to amplification and making excess protein
- Chromosome rearrangement that alters expression of gene or nature of product.
pRB helps regulate the passage of cells from:
G1 stage to S phase
RB
Retinoblastoma tumor suppressor gene. Both copies must be mutated or eliminated to result in a tumor
pRB targets ____ family of transcription factors which results in _______.
E2F; repression
______ is necessary for pRB to disassociate from E2F so transcription can proceed.
activation of cdk leads to phosphorylation of pRB
p53
Tumor suppressor responsible for repair of DNA damage. The p53 protein acts as a TF, activating genes that inhibit transition from G1 to S. If there is damage, p53 concentration rises. If a cell’s DNA is damaged beyond repair, p53 triggers apoptosis.
Mutation in p53 leads to:
No more G1 checkpoint control
Hereditary nonpolyposis colorectal cancer caused by:
Defect in DNA mismatch repair
Xeroderma pigmentosum caused by:
Defect in Nucleotide Excision Repair
Defects in repair of double stranded breaks by homologous recombination causes (3)
Bloom’s disease, Fanconi anemia, hereditary breast cancer (BRCA1 and 2 deficiencies)